Technical Analysis for NSPR - InspireMD, Inc.

Grade Last Price % Change Price Change
F 2.27 -0.87% -0.02
NSPR closed down 0.87 percent on Monday, March 18, 2024, on 2.25 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 28
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -0.87%
Gapped Up Strength -0.87%
Below Lower BB Weakness -0.87%
Lower Bollinger Band Touch Weakness -0.87%

   Recent Intraday Alerts

Alert Time
Up 3% about 16 hours ago
Up 2% about 16 hours ago
Reversed from Down about 19 hours ago
60 Minute Opening Range Breakout about 19 hours ago
2x Volume Pace about 20 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

InspireMD Inc., a medical device company, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its lead products include MGuard stent, an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent; and MGuard Prime, which include its mesh sleeve wrapped around a cobalt-chromium stent. The company markets its products for use primarily in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). It sells its products through distributors in Europe, southeast Asia, India, and Latin America. InspireMD Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Medical Device Interventional Radiology Platform Technology Cobalt Syndromes Veins Bypass Circulatory System Interventional Cardiology Heart Attack Stent Bypass Surgery Embolic Protection Device Infarction Myocardial Infarction Percutaneous Coronary Intervention

Is NSPR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.85
52 Week Low 0.9608
Average Volume 22,700
200-Day Moving Average 2.86
50-Day Moving Average 2.76
20-Day Moving Average 2.57
10-Day Moving Average 2.49
Average True Range 0.16
RSI (14) 32.43
ADX 19.94
+DI 8.68
-DI 25.28
Chandelier Exit (Long, 3 ATRs) 2.33
Chandelier Exit (Short, 3 ATRs) 2.63
Upper Bollinger Bands 2.84
Lower Bollinger Band 2.31
Percent B (%b) -0.07
BandWidth 20.70
MACD Line -0.10
MACD Signal Line -0.07
MACD Histogram -0.0326
Fundamentals Value
Market Cap 48.92 Million
Num Shares 21.5 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -1.76
Price-to-Sales 10.83
Price-to-Book 1.38
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.57
Resistance 3 (R3) 2.57 2.46 2.52
Resistance 2 (R2) 2.46 2.39 2.47 2.50
Resistance 1 (R1) 2.37 2.34 2.42 2.37 2.49
Pivot Point 2.26 2.26 2.29 2.27 2.26
Support 1 (S1) 2.17 2.19 2.22 2.17 2.05
Support 2 (S2) 2.06 2.14 2.07 2.04
Support 3 (S3) 1.97 2.06 2.02
Support 4 (S4) 1.97